Corwell Health Metabolomics Symposium
Corewell Health
Metabolomics Symposium
August 15, 2024 | 09:00 am – 05:00 pm (EST)
The Terrace, Corewell Health Place, Grand Rapids
Discover the Corewell Health Metabolomics Symposium, where speakers, researchers, and organizers illuminate the field of clinical metabolomics. Immerse yourself in captivating presentations from esteemed speakers, engage with others in the field during a poster session, and foster valuable connections through networking opportunities, all in a one-day, in-person symposium located in Grand Rapids, MI.
Metabolomics, with its focus on comprehensively studying small molecules in biological systems, holds the key to revolutionizing healthcare by offering personalized insights into disease risk, progression, and treatment responses. At this symposium, we’re committed to unraveling the intricate relationship between metabolomics and clinical applications, unveiling how metabolomics data can elevate precision medicine strategies. Join us as we delve into cutting-edge research, explore innovative methodologies, and unveil real-world applications, paving the path toward a future where metabolomics assumes a pivotal role in optimizing patient care and promoting wellness.
Poster session and abstract submission
If you are interested in presenting a poster at our event we are looking forward to your abstract. We value your input greatly.
Scientists in the field of metabolomics are invited to submit abstracts in the following scientific themes:
Metabolomics in human health and disease
Technology Advancements
Computational metabolomics, statistics & bioinformatics
Industry spotlight: Metabolomics in pharma and biotech
All abstracts will go through peer-review.
Before submitting your abstract please assemble the following limits:
Title – Limit 20 words
Introduction – Limit 120 words
Methods – Limit 120 words
Preliminary data – Limit 300 words
Novel aspect – Limit 20 words
DEADLINE for your abstract submission is August 01, 2024
If you want to provide your abstract after the deadline please reach out to marissa.jones@biocrates.com
By submitting an abstract, you are automatically registered.
Program overview
09:00 am – 05:00 pm EST
The Terrace, Corewell health place
648 Monroe Ave NW, Room 4500, Grand Rapids, MI, 49503
Introduction – 09:00 am EST
Steward Graham, Ph.D.
Corewell health
The John and Marilyn Bishop Charitable Foundation Endowed Chair and Director of Alzheimer’s Disease Research
Agenda | Speakers
Rima Kaddurah-Daouk, Ph.D.
Duke University Medical Center
Professor in Psychiatry and Behavior Sciences
09:15 – 10:00 am EST
Keynote: Precision therapeutics: Advances in treating neurodegenerative and mood disorders
Robert Nagourney, MD
Nagourney Cancer Institute
Medical and Laboratory Director
10:00 – 10:30 am EST
The application of quantitative metabolomics for diagnosis, prognosis and prediction of response in medical oncology
Marissa Jones, Ph.D.
biocrates life sciences ag
Business Development Manager
10:30 – 10:45 am EST
Metabolomics in chronic complex diseases
Randy Arnold, Ph.D.
SCIEX
Senior Accurate Mass and Advanced Workflow Specialist
10:45 – 11:00 am EST
Round table discussion
BREAK
11:00 – 11:15 am EST
Posters and lunch
11:15 am – 01:00 pm EST
Ryan Sheldon, Ph.D.
Mass Spectrometry Core at Van Andel Institute
Director
01:00 – 01:30 pm EST
Observer effects of metabolite extraction in metabolomics
Doug Guzior, Ph.D.
Panome Bio
Multi-Omic Analyst
01:30 – 02:00 pm EST
The new dogma of microbial bile acid metabolism
Randy Arnold
SCIEX
Senior Accurate Mass and Advanced Workflow Specialist
02:00 – 02:15 pm EST
Enabling new levels of quantification, ease of use and robustness for targeted omics
Marissa Jones, Ph.D.
biocrates life sciences ag
Business Development Manager
02:15 – 02:35 pm EST
Round table discussion | Q&A
BREAK
02:35 – 02:50 pm EST
Elora Hussain, MD
Helen Devos Children’s Hospital, Corewell Health West
Pediatric Neurocritical Care Physician
02:50 – 03:20 pm EST
Characterizing the metabolome in pediatric severe traumatic brain injury
Nadia Ashrafi, Ph.D.
Metabolomics Research Group
Corewell Health Research Institute
Corewell Health East William Beaumont University Hospital
Research Scientist
03:20 – 03:50 pm EST
Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease
Renzo Rendon-Loyaga, MD
Michigan State University
Advanced Heart Failure and Transplant Cardiologist,
Medical Director of Cardiovascular Research
03:50 – 04:20 pm EST
Pathways for recovery in end-stage Heart Failure
Marissa Jones, Ph.D.
biocrates life sciences ag
Business Development Manager
04:20 – 04:40 pm EST
Round table discussion
Stewart Graham, Ph.D.
Corewell Health
The John and Marilyn Bishop Charitable Foundation Endowed Chair and Director of Alzheimer’s Disease Research
04:40 – 04:50 pm EST